Cargando…
Protocol of the CONSORT and SPIRIT Extension for multicenter clinical trials
BACKGROUND: Multicenter clinical trials play an indispensable role for assessing the efficacy of a new intervention or treatment, particularly in Phase II or III studies. Previous studies have shown that these studies often suffer from inadequate reporting of key details related to their design, imp...
Autores principales: | Zhang, Xuan, Dong, Chongya, Wang, Nana, Chan, Chunpong, Lau, Chung Tai, Wang, Juan, Miao, Jiangxia, Yao, Chen, Li, Youping, Lyu, Aiping, Moher, David, Bian, Zhaoxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540686/ https://www.ncbi.nlm.nih.gov/pubmed/37780430 http://dx.doi.org/10.3389/fpubh.2023.1241152 |
Ejemplares similares
-
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
por: Manyara, Anthony Muchai, et al.
Publicado: (2022) -
Protocol for the development of a reporting guideline for clinical trials with integrated Chinese and western medicine interventions: the CONSORT extension for ICWM
por: Wang, Juan, et al.
Publicado: (2023) -
Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions
por: Ciani, Oriana, et al.
Publicado: (2022) -
Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines
por: Ibrahim, Hussein, et al.
Publicado: (2021) -
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
por: Solovyeva, Olga, et al.
Publicado: (2023)